CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
Biologicals
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
ABG Update Feature
Top 3 Tips for Formulators: How to Maximize Crop Protection Performance with Specialty Additives
Nouryon's Dr. Ruifei Wang shares pointers for formulators looking...
ABG Update Feature
U.S. Biostimulants Market: Driving Sustainable Agriculture to New Heights
Explore how innovative biostimulants are transforming American farming practices,...
ABG Update Feature
China Price Index: Structural Capacity Adjustments Drive Price Volatility for Glyphosate and Glufosinate
Glyphosate prices rebound amid tighter supply; glufosinate struggles with...
Industry News
U.S.: Coragen eVo Insect Control Now Registered for Use in California and Arizona
Coragen eVo leverages a highly concentrated formulation of Rynaxypyr...